RISK-FACTORS FOR ISONIAZID (INH)-INDUCED LIVER DYSFUNCTION

被引：75

作者：

DICKINSON, DS

BAILEY, WC

HIRSCHOWITZ, BI

SOONG, SJ

EIDUS, L

HODGKIN, MM

机构：

[1] UNIV ALABAMA,SCH MED,DIV GASTROENTEROL,BIRMINGHAM,AL 35233

[2] UNIV ALABAMA,SCH MED,DIV PULM DIS,BIRMINGHAM,AL 35233

[3] UNIV ALABAMA,SCH MED,DEPT BIOSTAT,BIRMINGHAM,AL 35233

[4] LAB CTR DIS CONTROL,OTTAWA K1A 0L2,ONTARIO,CANADA

[5] JEFFERSON CTY HLTH DEPT,BIRMINGHAM,AL

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 1981年 / 3卷 / 03期

关键词：

D O I：

10.1097/00004836-198109000-00012

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：271 / 279

页数：9

共 32 条

[1]

ASSEM ESK, 1969, CLIN EXP IMMUNOL, V5, P439

[2] EFFECT OF ISONIAZID ON TRANSAMINASE LEVELS [J].

BAILEY, WC ;

WEILL, H ;

DEROUEN, TA ;

ZISKIND, MM ;

JACKSON, HA ;

GREENBERG, HB .

ANNALS OF INTERNAL MEDICINE, 1974, 81 (02) :200-202

[3] DISTURBED HEPATIC FUNCTION DURING ISONIAZID CHEMOPROPHYLAXIS - MONITORING HEPATIC FUNCTION OF 427 HOSPITAL EMPLOYEES RECEIVING ISONIAZID CHEMOPROPHYLAXIS FOR TUBERCULOSIS [J].

BAILEY, WC ;

TAYLOR, SL ;

DASCOMB, HE ;

GREENBERG, HB ;

ZISKIND, MM .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 107 (04) :523-529

[4]

BERNSTEIN RE, 1980, AM REV RESPIR DIS, V121, P429, DOI 10.1164/arrd.1980.121.3.429

[5]

BLACK M, 1975, GASTROENTEROLOGY, V69, P289

[6]

BRENNAN RW, 1968, NEUROLOGY, V18, P283

[7] RISKS OF ISONIAZID THERAPY [J].

BROWN, A .

ANNALS OF INTERNAL MEDICINE, 1976, 85 (06) :828-829

[8] TOXIC EFFECTS OF ISONIAZID IN TUBERCULOSIS CHEMOPROPHYLAXIS - ROLE OF BIOCHEMICAL MONITORING IN 1,000 PATIENTS [J].

BYRD, RB ;

HORN, BR ;

SOLOMON, DA ;

GRIGGS, GA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (12) :1239-1241

[9] ISONIAZID TOXICITY - PROSPECTIVE STUDY IN SECONDARY CHEMOPROPHYLAXIS [J].

BYRD, RB ;

ELLIOTT, RC ;

NELSON, R .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 220 (11) :1471-+

[10]

Cox D. R., 1989, BIOMETRICS, V32, DOI DOI 10.2307/2531476

← 1 2 3 4 →